Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease

E-ISSN： 1873-4294|16|12|1351-1361

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.12, 2016-03, pp. : 1351-1361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C NS3 protease inhibitors

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 663-665

Informa Healthcare

Access to resources Recommend Favorite

QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors

Medicinal Chemistry, Vol. 9, Iss. 6, 2013-09 ,pp. : 774-805

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

Current Pharmaceutical Design, Vol. 23, Iss. 30, 2017-11 ,pp. : 4493-4554

Bentham Science Publishers

Access to resources Recommend Favorite